New flights between Cornwall and London are set to start later this summer, an airline has said. EasyJet has announced a new ...
Pearson plc is leveraging AI-driven efficiency and digital transformation to drive sustained margin expansion and free cash flow growth. Learn more about PSO stock here.
Falmouth Packet on MSN
Easyjet to start new routes from Cornwall this summer
One month after a decision was made to discontinue Skybus flights from Newquay to London, a major airline has announced it ...
One-year Phase 3 data for ICOTYDE to be presented at AAD 2026 demonstrate lasting skin clearance and a favorable safety ...
A UK airline operating between London and Cornwall has cancelled flights from today (April 3) partly due to the 'huge rise in ...
A new domestic route has been launched by easyJet that could make staycations in the coastal spot much easier, and the budget ...
Two Phase 3 clinical studies evaluated the efficacy and safety of zasocitinib in patients with moderate to severe plaque psoriasis and found promising results. Approximately 70% of ...
Johnson & Johnson (NYSE: JNJ) today announced new long-term 52-week data from the Phase 3 ICONIC-ADVANCE 1 and 2 and ICONIC-LEAD studies, which assessed the efficacy and safety of ICOTYDE™ ...
Pittsburgh Symphony performances arrive at One PPG Place, extending the experience from airport to downtown At the ...
Envudeucitinib, another allosteric TYK2 inhibitor, also achieved PASI 75 in 70-75% of patients at 16 weeks and PGA 0/1 status ...
Mar 28, 2026-- Takeda ( TSE:4502/NYSE:TAK ) today announced new data from the two pivotal Phase 3 studies of zasocitinib (TAK-279 ...
71.4% and 69.2% of patients treated with zasocitinib achieved a static Physician Global Assessment (sPGA) score of 0/1 versus placebo (10.7% and 12.6%) and apremilast (32.1% and 29.7%) at week 16 (p<0 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results